News / Information - Viracept 50 mg Oral Powder Discontinuation
Jul 26, 2011
Viracept 50 mg Oral Powder 63010-011-90 Discontinuation Letter
Effective immediately, ViiV Healthcare will discontinue Viracept? (nelfinavir mesylate) Oral Powder. GlaxoSmithKline (GSK) provides trade distribution services for ViiV Healthcare and, accordingly, is sending this communication on their behalf.